Chapter XI
DRUG STUDY
DATE/
TIME
ORDERED
11/30/15
5:30 am
BRAND
NAME
Biogesic
GENERIC
NAME
Paracetamol
CLASSIFI
-CATION
Analgesic,
antipyretic
ACTION
INDICATION
Unknown. Mild pain
Thought
or fever
to produce
analgesia
by
blocking
pain
impulses,
probably
by
inhibiting
synthesis
of
prostaglan
din in the
CNS
ROUTE/DOSAGE/
TIME INTERVAL
Orally, 500mg
every 4 hours
PRN
Onset:Unknown
Peak: - 2
hours
Duration: 3-4
hours
HALF-LIFE
1-4 hours
ABSORPTION
Readily
absorbed from
DRUG
INTERACTIO
N
Barbiturates,
carbamazepine,
rifampin,
sulfinpyrazone:
high doses or
long term use of
these drugs may
reduce
therapeutic
effects and
ehanceheptotoxi
c effects of
paracetamol
Drug-food:
Caffeine: May
enhance
analgesic effects
of paracetamol
EXCRETION
Urine 85% -90%
ADVERSE
EFFECT
PRECAUTION
CONTRAINDICATIONS
CV: hemolytic
anemia,
leukopenia,
neutropenia,
pancytopenia,
thrombocytopen
ia
Hypersensitivit
y drugs
snfacute
intoxication
with alcohol
Hepatic:
Liver damage,
jaundice
Metabolic:
hypoglycemia
NURSING
RESPONSIBILITES
Skin: rash,
urticaria
Use liquid
form for
children with
difficulty in
swallowing.
Dont exceed 5
doses in 24
hours
Tell patient that
drug is only for
short term use
Tell patient to
not use for
fever
exceeding
39.5oC or those
exceeding 3
days unless
prescribed
Warn patient
that long term
the
gastrointestinal
tract
use can cause
liver damage
DATE/
TIME
ORDERED
11/30/15
5:30 am
BRAND
NAME
Zantac
ACTION
Ranitidine
blocks
histamine
Generic
H2Name
receptors
ranitidine
the
hydrochlori in
stomach
de
and
CLASSIFIprevents
CATION
histamineH2
mediated
antagonist
gastric acid
secretion.
It does not
affect
pepsin
secretion,
pentagastri
nstimulated
factor
secretion
or serum
gastrin.
INDICATION
ROUTE/DOSAGE/
TIME INTERVAL
Treatment
and
prevention
of
indigestio
n, and
sour
stomach.
Orally, 1 tab 150
mg bid
Prophylax
is of GI
hemorrhag
e from
stress
ulceration
Half-life
2.5-3 hours
Onset: 1 hour
DRUG
INTERACTION
ADVERSE
EFFECT
PRECAUTION
CONTRAINDICATIONS
Antacids: may
interfere with
absorption
CNS:vertigo,
malaise,
headache
EENT:blurre
d vision
Hepatic:
jaundice
Other:
burning and
itching at
injection site
Contraindicate
d to patients
hypersensitive
to drug and
those with
acute
porphyria
Peak: 1 3 hours
Duration: 13 hours
Absorption
Excretion
50% absorbed after
oral administration
Renal,
unchanged
NURSING
RESPONSIBILITES
Use cautiously
in patients with
hepatic
dysfunction
Instruct patient not
to take new
medication w/o
consulting
physician
Instruct patient to
take as directed and
do not increase
dose
Allow 1 hour
between any other
antacid and
ranitidine
Avoid excessive
alcohol
Assess patient for
epigastric or
abdominal pain and
frank or occult
blood in the stool,
emesis, or gastric
aspirate
Nurse should know
that it may cause
false-positive
results for urine
protein; test with
sulfosalicylic acid
Inform patient that
it may cause
drowsiness or
dizziness
Inform patient that
increased fluid and
fiber intake may
minimize
constipation
Advise patient to
report onset of
black, tarry stools;
fever, sore throat;
diarrhea; dizziness;